Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 135

Sort by

Sort Order Select

Journal Articles

Tisagenlecleucel for the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Interim Report of the European Post-Authorisation Safety Study Conducted By EBMT

Blood (2024) 144 (Supplement 1): 607.

https://doi.org/10.1182/blood-2024-200367

Published: 2024

Journal Articles

CAR-T Cells for Systemic Lupus Erythematosus

Matteo Doglio, Alessia Ugolini, Clara Bercher, Cristiano Toma, Chiara Bonini, Fabio Ciceri, Barbara Camisa, Rossana Norata, Stefania Del Rosso, Francesca Sanvito, Monica Casucci, Angelo Manfredi

Blood (2023) 142 (Supplement 1): 6813.

https://doi.org/10.1182/blood-2023-189673

Published: 2023

Journal Articles

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

Blood (2023) 142 (10): 865–877.

https://doi.org/10.1182/blood.2023020578

Published: 2023

Includes: Supplemental data

Journal Articles

NTLA5001, a T Cell Product Candidate with CRISPR-Based Targeted Insertion of a High-Avidity, Natural, WT1-Specific TCR, Shows Efficacy in In Vivo Models of AML and ALL

Eliana Ruggiero, PhD, Dai Liu, PhD, Aaron Prodeus, PhD, Amy M Becker, PhD, Maxwell Foisey, BS, Ishina Balwani, MS, Ivy Dutta, MS, Qingzhan Zhang, PhD, Simo M Arredouani, PhD, Mark McKee, MD, Fabio Ciceri, MD, Laura Sepp-Lorenzino, PhD, Chiara Bonini, MD, Birgit C Schultes, PhD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-143119

Published: 2020

Journal Articles

Addressing Toxicities Following Cellular Therapy

Chiara Bonini, MD

Blood (2020) 136 (Supplement 1): SCI1.

https://doi.org/10.1182/blood-2020-133095

Published: 2020

Journal Articles

CMV-Specific T Cells Restricted By Shared and Donor, but Not By Host HLA Molecules Reconstitute in the First 180 Days after Allogeneic HSCT and Protect from CMV Reactivation: Results of a Prospective Observational Study

Maddalena Noviello, PhD, Elena Tassi, PhD, Pantaleo De Simone, MD, Francesca Serio, MD, Maria Teresa Lupo Stanghellini, Giacomo Oliveira, PhD, Sara Racca, Dr, Roee Dvir, MD, Lorenzo Lazzari, MD, Daniela Clerici, MD, Fabio Giglio, MD, Francesca Lorentino, MD, Consuelo Corti, MD, Massimo Bernardi, MD, Liselotte Brix, PhD, Fabio Ciceri, MD, Jacopo Peccatori, MD, Raffaella Greco, MD, Chiara Bonini, MD

Blood (2019) 134 (Supplement_1): 4536.

https://doi.org/10.1182/blood-2019-129779

Published: 2019

Journal Articles

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2019) 134 (Supplement_1): 3281.

https://doi.org/10.1182/blood-2019-125369

Published: 2019

Journal Articles

Generation of Memory Stem T Cells Specific for Tumor Antigens and Resistant to Inhibitory Signals By Genome Editing

Beatrice Claudia Cianciotti, Alessia Potenza, Valentina Vavassori, Zulma Magnani, Luigi Naldini, MD PhD, Fabio Ciceri, MD, Pietro Genovese, PhD, Eliana Ruggiero, PhD, Chiara Bonini, MD

Blood (2018) 132 (Supplement 1): 2202.

https://doi.org/10.1182/blood-2018-99-118201

Published: 2018

Journal Articles

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Lucia Zanotti, PhD, Gabriele Bucci, PhD, Francesco Santaniello, Cristina Toffalori, Donatella Biancolini, PhD, Ettore Zapparoli, Laura Zito, Matteo Giovanni Carrabba, MD, Friedrich Stoelzel, Martin Bornhäuser, Massimo Bernardi, MD, Jacopo Peccatori, Chiara Bonini, MD, Davide Cittaro, PhD, Dejan Lazarevic, Giovanni Tonon, MD PhD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2018) 132 (Supplement 1): 819.

https://doi.org/10.1182/blood-2018-99-111769

Published: 2018

Journal Articles

Combining De-Glycosylating Agents with CAR-T Cells for Targeting Solid Tumors and Reducing Toxicity

Beatrice Greco, MSc, Katia Paolella, Barbara Camisa, Valeria Malacarne, PhD, Laura Falcone, Andrea Graziani, PhD, Chiara Bonini, MD, Attilio Bondanza, MD, Monica Casucci, PhD

Blood (2018) 132 (Supplement 1): 4544.

https://doi.org/10.1182/blood-2018-99-116019

Published: 2018

Journal Articles

Immune Reconstitution Is a Predictive Biomarker of Chronic Graft-Versus-Host Disease: Analysis of 307 Consecutive Patients

Blood (2018) 132 (Supplement 1): 4579.

https://doi.org/10.1182/blood-2018-99-113855

Published: 2018

Journal Articles

Exhausted Central Memory and Memory Stem T Cells Specific for Leukemia Infiltrate the Bone Marrow of AML Patients Relapsing after Allogeneic HSCT

Francesco Manfredi, MD, Maddalena Noviello, PhD, Eliana Ruggiero, PhD, Tommaso Perini, MD, Giacomo Oliveira, PhD, Filippo Cortesi, PhD, Pantaleo De Simone, MD, Cristina Toffalori, Valentina Gambacorta, MSc, Raffaella Greco, MD, Jacopo Peccatori, Monica Casucci, PhD, Giulia Casorati, PhD, Paolo Dellabona, MD PhD, Nicoletta Cieri, MD PhD, Attilio Bondanza, MD, Luca Vago, MD PhD, Fabio Ciceri, MD, Chiara Bonini, MD

Blood (2018) 132 (Supplement 1): 2028.

https://doi.org/10.1182/blood-2018-99-118104

Published: 2018

Journal Articles

Endocrinopathies Following Allogeneic Stem Cell Transplantation: 10 Years Follow-up in 402 Patients

Blood (2018) 132 (Supplement 1): 4600.

https://doi.org/10.1182/blood-2018-99-117293

Published: 2018

Journal Articles

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications

Antonio Russo, Giacomo Oliveira, Sofia Berglund, Raffaella Greco, Valentina Gambacorta, Nicoletta Cieri, Cristina Toffalori, Laura Zito, Francesca Lorentino, Simona Piemontese, Mara Morelli, Fabio Giglio, Andrea Assanelli, Maria Teresa Lupo Stanghellini, Chiara Bonini, Jacopo Peccatori, Fabio Ciceri, Leo Luznik, Luca Vago

Blood (2018) 131 (2): 247–262.

https://doi.org/10.1182/blood-2017-05-780668

Published: 2018

Includes: Supplemental data

Journal Articles

Early and Profound Exhausted Phenotype of Central Memory and Memory Stem T Cells in the Bone Marrow of AML Patients Characterizes and Predicts Relapse after Allo-HSCT

Maddalena Noviello, PhD, Francesco Manfredi, MD, Tommaso Perini, MD, Oliveira Giacomo, PhD, Filippo Cortesi, PhD, Pantaleo De Simone, MD, Cristina Toffalori, PhD, Valentina Gambacorta, MSc, Attilio Bondanza, MD, Raffaella Greco, MD, Jacopo Peccatori, MD, Giulia Casorati, PhD, Paolo Dellabona, MD PhD, Nicoletta Cieri, MD PhD, Luca Vago, MD PhD, Fabio Ciceri, MD, Chiara Bonini, MD

Blood (2017) 130 (Supplement 1): 4491.

https://doi.org/10.1182/blood.V130.Suppl_1.4491.4491

Published: 2017

Journal Articles

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease

Blood (2017) 130 (5): 606–618.

https://doi.org/10.1182/blood-2016-08-732636

Published: 2017

Includes: Supplemental data

Journal Articles

How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT- Cellular Therapy & Immunobiology Working Party

Raffaella Greco, MD, Fabio Ciceri, MD, Maddalena Noviello, PhD, Attilio Bondanza, MD PhD, Luca Vago, MD PhD, Giacomo Oliveira, PhD, Jacopo Peccatori, MD, Nicoletta Cieri, MD PhD, Annalisa Ruggeri, Ulrike Koehl, Katharina Fleischhauer, MD, Vanderson Rocha, MD PhD, Francesco Dazzi, PhD, Steffie Maria van der Werf, Sofie Rosanne Terwel, Antoine Toubert, Christian Chabannon, MD PhD, Chiara Bonini, MD

Blood (2016) 128 (22): 4581.

https://doi.org/10.1182/blood.V128.22.4581.4581

Published: 2016

Journal Articles

Haploidentical Peripheral Blood Stem Cell Transplantation after Treosulfan-Based Conditioning and Rapamycin GvHD Prophylaxis in Hodgkin Lymphoma

Mara Morelli, MD, Lorenzo Lazzari, MD, Francesca Lorentino, MD, Raffaella Greco, MD, Fabio Giglio, MD, Andrea Angelo Assanelli, MD, Magda Marcatti, MD, Serena Camilla Dalto, MD, Sarah Marktel, MD, Raffaella Milani, Michela Giulia Tassara, MD, Maria Teresa Lupo Stanghellini, MD, Chiara Bonini, MD, Jacopo Peccatori, MD, Fabio Ciceri, MD

Blood (2016) 128 (22): 4670.

https://doi.org/10.1182/blood.V128.22.4670.4670

Published: 2016

Journal Articles

Impact of Immune Reconstitution (IR) and Graft-Versus-Host Disease (GvHD) on Clinical Outcomes after Treatment with Donor T Cells Transduced to Express the Herpes Simplex Virus Thymidine-Kinase Suicide Gene (TK cells) in Acute Leukemia Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Blood (2016) 128 (22): 4599.

https://doi.org/10.1182/blood.V128.22.4599.4599

Published: 2016

Journal Articles

Clinical and Biological Features Associated with Engraftment of Acute Myeloid Leukemia Patient-Derived Xenografts

Giacomo Oliveira, PhD, Gabriele Bucci, PhD, Cristina Toffalori, PhD, Carolina Caserta, Lara Crucitti, MD, Barbara Camisa, BSc, Raffaella Greco, MD, Francesca Biavasco, Lucia Zanotti, PhD, Laura Zito, MSc, Jose Manuel Garcia-Manteiga, PhD, Dejan Lazarevic, MD, Matteo Giovanni Carrabba, MD, Massimo Bernardi, MD, Attilio Bondanza, MD PhD, Chiara Bonini, MD, Fabio Ciceri, MD, Luca Vago, MD PhD

Blood (2016) 128 (22): 2858.

https://doi.org/10.1182/blood.V128.22.2858.2858

Published: 2016

NARROW

Tisagenlecleucel for the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Interim Report of the European Post-Authorisation Safety Study Conducted By EBMT

CAR-T Cells for Systemic Lupus Erythematosus

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

NTLA5001, a T Cell Product Candidate with CRISPR-Based Targeted Insertion of a High-Avidity, Natural, WT1-Specific TCR, Shows Efficacy in In Vivo Models of AML and ALL

Addressing Toxicities Following Cellular Therapy

CMV-Specific T Cells Restricted By Shared and Donor, but Not By Host HLA Molecules Reconstitute in the First 180 Days after Allogeneic HSCT and Protect from CMV Reactivation: Results of a Prospective Observational Study

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Generation of Memory Stem T Cells Specific for Tumor Antigens and Resistant to Inhibitory Signals By Genome Editing

Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse

Combining De-Glycosylating Agents with CAR-T Cells for Targeting Solid Tumors and Reducing Toxicity

Immune Reconstitution Is a Predictive Biomarker of Chronic Graft-Versus-Host Disease: Analysis of 307 Consecutive Patients

Exhausted Central Memory and Memory Stem T Cells Specific for Leukemia Infiltrate the Bone Marrow of AML Patients Relapsing after Allogeneic HSCT

Endocrinopathies Following Allogeneic Stem Cell Transplantation: 10 Years Follow-up in 402 Patients

NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications

Early and Profound Exhausted Phenotype of Central Memory and Memory Stem T Cells in the Bone Marrow of AML Patients Characterizes and Predicts Relapse after Allo-HSCT

NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease

How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT- Cellular Therapy & Immunobiology Working Party

Haploidentical Peripheral Blood Stem Cell Transplantation after Treosulfan-Based Conditioning and Rapamycin GvHD Prophylaxis in Hodgkin Lymphoma

Clinical and Biological Features Associated with Engraftment of Acute Myeloid Leukemia Patient-Derived Xenografts

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only